Concepedia

Diana Giannarelli

DG

Statistics

Publications

376

Citations

20.9K

H-Index

72

Active since

1984

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

National Cancer Institute

Sapienza University of Rome

Agostino Gemelli University Polyclinic

Fondazione IRCCS Istituto Nazionale dei Tumori

Diana Giannarelli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1984–2025

376

Publications

376

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

Pierluigi Benedetti Panici, S. Basile, F. Maneschi et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.6K citations · Full text

, , +14

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Mariaelena Capone, Diana Giannarelli, Domenico Mallardo et al. · Journal for ImmunoTherapy of Cancer · 2018 · 511 citations · Full text

, , +17

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

Pier Francesco Ferrucci, Paolo A. Ascierto, Jacopo Pigozzo et al. · Annals of Oncology · 2016 · 395 citations · Full text

, , +17

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

Antonio Maria Grimaldi, Ester Simeone, Diana Giannarelli et al. · OncoImmunology · 2014 · 373 citations · Full text

, , +17

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Luana Calabrò, Aldo Morra, Ester Fonsatti et al. · The Lancet Oncology · 2013 · 354 citations

, , +11

1–5 of 376